Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adenocarcinoma of Lung × Orlistat × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 2 Obesity 1 Adenocarcinoma of Lung 1

Interventions

Carboplatin 32 Bevacizumab 25 Pemetrexed 24 Cisplatin 23 Paclitaxel 21 Gemcitabine 20 Docetaxel 17 Radiotherapy 16 Erlotinib Hydrochloride 12 Gefitinib 10 pembrolizumab 6 Cetuximab 6 Surgical Procedures, Operative 5 Vinorelbine 4 Radiosurgery 4 Metformin 4 durvalumab 3 capmatinib 3 aflutinib 3 Sorafenib 3 Platinum 3 Nivolumab 3 Neoadjuvant Therapy 3 Magnetic Resonance Spectroscopy 3 pegfilgrastim 2 osimertinib 2 icotinib 2 ceritinib 2 apatinib 2 Temozolomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06818955 2025-02-12

OOTER

Tongji Hospital

Phase 2 Not yet recruiting

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡